136 related articles for article (PubMed ID: 38411300)
1. Lacosamide and pregnancy: Data from spontaneous and solicited reports.
Perucca P; Bourikas D; Voinescu PE; Vadlamudi L; Chellun D; Kumke T; Werhahn KJ; Schmitz B
Epilepsia; 2024 May; 65(5):1275-1284. PubMed ID: 38411300
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results on pregnancy outcomes in women using lamotrigine.
Tennis P; Eldridge RR;
Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
[TBL] [Abstract][Full Text] [Related]
3. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
[TBL] [Abstract][Full Text] [Related]
4. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series.
Bosak M; Dziedzic R; Matwiej K; Słowik A
Neurol Neurochir Pol; 2024; 58(2):203-206. PubMed ID: 38305480
[TBL] [Abstract][Full Text] [Related]
5. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
Thomas SV; Jose M; Divakaran S; Sankara Sarma P
Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.
Clowse MEB; Scheuerle AE; Chambers C; Afzali A; Kimball AB; Cush JJ; Cooney M; Shaughnessy L; Vanderkelen M; Förger F
Arthritis Rheumatol; 2018 Sep; 70(9):1399-1407. PubMed ID: 29623679
[TBL] [Abstract][Full Text] [Related]
7. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
8. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
[TBL] [Abstract][Full Text] [Related]
9. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
Kalilani L; Halpern R; Seare J; Dedeken P
Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
[TBL] [Abstract][Full Text] [Related]
10. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of Lacosamide in pediatric patients with epilepsy under four years: Results from a prospective cohort study in China.
Xiong L; He H; Wang D; Liu T; Xiao N
Seizure; 2024 May; 118():71-79. PubMed ID: 38643678
[TBL] [Abstract][Full Text] [Related]
12. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide.
Hoeltzenbein M; Slimi S; Fietz AK; Stegherr R; Onken M; Beyersmann J; Dathe K; Schaefer C
Seizure; 2023 Apr; 107():107-113. PubMed ID: 37003184
[TBL] [Abstract][Full Text] [Related]
13. The teratogenic risk of antiepileptic drug polytherapy.
Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ
Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes.
AlSheikh MH
Neurosciences (Riyadh); 2020 Jan; 25(1):32-37. PubMed ID: 31982897
[TBL] [Abstract][Full Text] [Related]
15. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome?
Asranna A; Jose M; Philip RM; Sarma PS; Thomas SV
Epilepsy Res; 2018 Oct; 146():121-125. PubMed ID: 30098567
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drug use during pregnancy: perinatal outcomes.
Kulaga S; Sheehy O; Zargarzadeh AH; Moussally K; Bérard A
Seizure; 2011 Nov; 20(9):667-72. PubMed ID: 21763158
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide serum concentrations during pregnancy.
Zutshi D; Millis SR; Basha MM; Daimee MA; Srinivas M
Epilepsy Behav; 2021 Oct; 123():108253. PubMed ID: 34399392
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study.
Casciato S; Quarato PP; Gialluisi A; D'Aniello A; Mascia A; Grammaldo LG; Di Gennaro G
Epilepsy Behav; 2021 Sep; 122():108128. PubMed ID: 34229159
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
